EW vs RL · P/E 47, rev $1.39B vs P/E 24, rev $8.11B
Edwards Lifesciences Corp (EW) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the EW and RL stock pages for the full models.
Not investment advice.